Immune-Checkpoint-Inhibitor-Related Bullous Pemphigoid During Avelumab Maintenance Therapy in a Patient With Metastatic Renal Pelvic Carcinoma: A Case Report.

Nara T, Furihata K, Kikuchi A, Sekine Y, Sato H, Kobayashi M, Yamamoto R, Saito M, Narita S, Habuchi T

Open source

DOI
10.1002/iju5.70240
Published
2026 Sep
Container
IJU case reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/iju5.70240,
  title = {Immune-Checkpoint-Inhibitor-Related Bullous Pemphigoid During Avelumab Maintenance Therapy in a Patient With Metastatic Renal Pelvic Carcinoma: A Case Report.},
  author = {Nara T and Furihata K and Kikuchi A and Sekine Y and Sato H and Kobayashi M and Yamamoto R and Saito M and Narita S and Habuchi T},
  year = {2026},
  journal = {IJU case reports},
  doi = {10.1002/iju5.70240},
  url = {https://doi.org/10.1002/iju5.70240}
}

RIS

TY  - JOUR
TI  - Immune-Checkpoint-Inhibitor-Related Bullous Pemphigoid During Avelumab Maintenance Therapy in a Patient With Metastatic Renal Pelvic Carcinoma: A Case Report.
AU  - Nara T
AU  - Furihata K
AU  - Kikuchi A
AU  - Sekine Y
AU  - Sato H
AU  - Kobayashi M
AU  - Yamamoto R
AU  - Saito M
AU  - Narita S
AU  - Habuchi T
PY  - 2026
JO  - IJU case reports
DO  - 10.1002/iju5.70240
UR  - https://doi.org/10.1002/iju5.70240
ER  - 

APA

T, N., K, F., A, K., Y, S., H, S., M, K., R, Y., M, S., S, N., & T, H. (2026). Immune-Checkpoint-Inhibitor-Related Bullous Pemphigoid During Avelumab Maintenance Therapy in a Patient With Metastatic Renal Pelvic Carcinoma: A Case Report.. IJU case reports. https://doi.org/10.1002/iju5.70240

Source records